Dr. Pauline M. Camacho is a Professor of Medicine at Loyola University Medical Center and directs the Loyola University Osteoporosis and Metabolic Bone Disease Center. She is also the Program Director for the Endocrinology fellowship at Loyola.

She obtained her medical degree from the University of the Philippines College of Medicine, and completed her Internal Medicine residency at Rush University Medical Center and endocrinology fellowship at Loyola University Medical Center.

Her clinical practice and research focuses on osteoporosis and other metabolic bone diseases such as vitamin D deficiency, primary hyperparathyroidism and other calcium and mineral disorders.

She has authored numerous publications, including four books in Endocrinology. She is the lead author on the 2020 AACE/ACE Postmenopausal Osteoporosis Treatment Guidelines, and has helped author several of AACE’s Guidelines.

Dr. Camacho is a Past President of the American Association of Clinical Endocrinologists (AACE) and Past Chancellor of the American College of Endocrinology.

Aliya Khan is a Professor of  Clinical Medicine at McMaster University. She is the Director of the Calcium Disorders Clinic and the Fellowship in Metabolic Bone Disease at McMaster University. She graduated from the University of Ottawa Medical School with Honors and completed postgraduate training at the University of Toronto. She has published over  200 scientific papers  and numerous books  and chapters on osteoporosis and parathyroid disease.

Dr. Khan has received numerous national and international awards including the Queen’s Diamond Jubilee Medal for excellence in clinical care, research and teaching , International Hypoparathyroidism Award , International Osteoporosis Foundation award for publishing excellence and recognized by Osteoporosis Canada for outstanding contributions to research and education.  She was recognized as being in the top 0.1% of the world experts in hyperparathyroidism by Expertscape.   

Dr. Michael McClung is the founding director of the Oregon Osteoporosis Center. He trained at the University of Texas Southwestern Medical School in Dallas and completed a fellowship in Endocrinology at the National Institutes of Health in Bethesda, Maryland. For more than 40 years. Dr. McClung has cared for patients with osteoporosis and related diseases, taken part in multiple educational initiatives and has been the principal investigator in many clinical trials evaluating the effects of therapeutic agents for osteoporosis. He has more than 250 scientific and clinical publications, is frequently invited to speak at national and international society meetings and is the recipient of several teaching and service awards from those societies. Dr. McClung serves on the Boards of the International Osteoporosis Foundation and the North American Menopause Society.

Dr. Petak is a past president of the American Association of Clinical Endocrinologists, the American College of Endocrinology (www.aace.com), and the International Society for Clinical Densitometry (www.iscd.org).  He is an associate clinical professor at Weill-Cornell Medical College at the Houston Methodist Hospital and is the division head of endocrinology, diabetes and metabolism as well as service chief of endocrinology. He is  a bone densitometry and endocrine consultant to NASA at the Johnson Space Center for about 13 years and has been a part of the bone summit planning long duration space missions. He is the secretary of the board of councilors of the Texas Medical Association (2015) and represents the Harris County Medical Society as vice-councilor. 

His awards include Master of the American College of Endocrinology, Yank Coble Public Service Award of the American College of Endocrinology, the ISCD Paul Miller Public Service Award, and ISCD Clinician of the Year. He has authored and co-authored articles, editorials and guidelines in endocrinology and reproductive medicine.